Rates of complete diagnostic testing for patients with acute myeloid leukemia

In addition to cytogenetics, additional molecular markers of prognosis have been identified and incorporated into the management of patients with acute myeloid leukemia (AML). We hypothesized that rates of molecular testing would be higher in an academic center versus community sites. A retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tara L, Williams, Travis, He, Jianghua, Aljitawi, Omar S, Ganguly, Siddhartha, Abhyankar, Sunil, Fleming, Allan, Male, Heather, McGuirk, Joseph P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402066/
https://www.ncbi.nlm.nih.gov/pubmed/25620650
http://dx.doi.org/10.1002/cam4.406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402066/
https://www.ncbi.nlm.nih.gov/pubmed/25620650
http://dx.doi.org/10.1002/cam4.406

Ejemplares similares